ArticleThe journal of cardiovascular aging2024

Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia.

Oliver M Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.